Immunic
-$0.05 (-0.83%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunic and other ETFs, options, and stocks.
About IMUX
Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis.
CEO
Daniel Vitt
Employees
55
Headquarters
New York, New York
Founded
2003
IMUX Key Statistics
Market cap
183.24M
Price-Earnings ratio
—
Dividend yield
—
Average volume
340.59K
High today
$6.21
Low today
$5.82
Open price
$5.98
Volume
300.08K
52 Week high
$15.12
52 Week low
$4.96
Analyst ratings
100%
of 7 ratings
Buy
100%
Hold
0%
Sell
0%
IMUX Earnings
-$1.63
-$1.09
-$0.54
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 5, Pre-Market